Delivery Order SPE2DB22D1106-SPE2DB25FDMR0
Award Date
11/21/24
Potential Completion Date
11/22/24
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $37,962.81, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting, to support DLA's medical supply requirements. The contract has an ultimate completion date of November 29, 2024 and is a Firm Fixed Price Delivery Order. No set-aside designation was...
This federal contract award, valued at $7,915.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting, in quantities of 30 tablets per order. The contract has a completion date of January 28, 2025 and is a Firm Fixed Price Delivery Order with no set-aside designation. AmerisourceBergen...
This federal contract award, valued at $4,851.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract is a firm-fixed-price delivery order with an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $4,922.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The contract is a Firm Fixed Price Delivery Order with a completion date of July 3, 2024. The contract is not set aside for any specific business type. Amerisourcebergen also holds...
This federal contract award, valued at $3,069.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,062,083 units of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 29, 2025. The contract is not set-aside and is open to competition....
This federal contract award, valued at $2,763.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for Ondansetron ODT 4 mg tablets, which are used to prevent nausea and vomiting. The contract has a Firm Fixed Price pricing type and an ultimate completion date of November 1, 2024. This award is not associated with a set-aside designation, indicating open...
This federal contract award, valued at $3,100.96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication commonly used to treat nausea and vomiting. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 8, 2025. The contract is not designated as a set-aside...
This federal contract award, valued at $13,518.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,073,388 units of the medication Ondansetron ODT 4 mg tablet, a drug used to treat nausea and vomiting. The contract has a firm fixed-price pricing type and an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp holds a...
This federal contract award, valued at $32,205.94, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. This is a firm-fixed-price delivery order contract with a completion date of December 19, 2023. The award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $4,739.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ondansetron ODT 4 mg Tablets, a medication commonly used to treat nausea and vomiting. The contract type is a Delivery Order with a Firm Fixed Price, and the ultimate completion date is April 22, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...